-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, CMJ79RQwE/hsYLuVSwP+y43Z8/uNxZ7F5wB8fLMXvrtZHeNuRQ47ViK61sGsawX8 3K0+w7f1nt02h71G5E0Rew== 0000950123-06-004519.txt : 20060411 0000950123-06-004519.hdr.sgml : 20060411 20060411155614 ACCESSION NUMBER: 0000950123-06-004519 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20060411 DATE AS OF CHANGE: 20060411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OSI PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000729922 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133159796 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: 1933 Act SEC FILE NUMBER: 333-132718 FILM NUMBER: 06753726 BUSINESS ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 BUSINESS PHONE: 631-962-2000 MAIL ADDRESS: STREET 1: 41 PINELAWN ROAD CITY: MELVILLE STATE: NY ZIP: 11747 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENE SCIENCE INC DATE OF NAME CHANGE: 19920703 424B3 1 y19683e424b3.htm 424B3 424B3
 

PROSPECTUS SUPPLEMENT NO. 2 DATED APRIL 11, 2006 Filed Pursuant to Rule 424(b)(3) and (c)
(To Prospectus dated March 24, 2006) Registration No. 333-132718

$115,000,000
(OSI PHARMACEUTICALS LOGO)
2% Convertible Senior Subordinated Notes due 2025
and 3,908,241 Shares of Common Stock
Issuable Upon Conversion of the Notes
       This Prospectus Supplement relates to resales by selling securityholders of our 2% Convertible Senior Subordinated Notes due 2025 and shares of our common stock into which the notes are convertible.
      This Prospectus Supplement must be read in conjunction with the Prospectus dated March 24, 2006 (the “Prospectus”).
      SEE “RISK FACTORS” BEGINNING ON PAGE 5 OF THE PROSPECTUS, AS THEY MAY BE MODIFIED AND INCORPORATED BY REFERENCE, TO READ ABOUT FACTORS YOU SHOULD CONSIDER BEFORE BUYING THE NOTES OR OUR COMMON STOCK.
      NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.
The date of this Prospectus Supplement is April 11, 2006


 

SELLING SECURITYHOLDERS
      The information in the table appearing in the Prospectus under the heading “Selling Securityholders” is superseded by the information appearing in the following table based on information provided to us by the selling securityholders as of April 10, 2006:
                                                 
    Principal       Number of            
    Amount of   Number of   Shares of            
    Notes   Shares of   Common   Principal   Number of    
    Beneficially   Common   Stock Issuable   Amount of   Shares of   Percentage of
    Owned Prior   Stock   Upon   Notes   Common Stock   Common Stock
    to the   Beneficially   Conversion of   Beneficially   Beneficially   Outstanding
    Offering and   Owned Prior   the Notes That   Owned Upon   Owned Upon   Upon
    That May   to the   May be   Completion of   Completion of   Completion of
Selling Securityholder   be Offered   Offering(1)   Offered(2)   the Offering(3)   the Offering(3)   the Offering(4)
                         
Allstate Insurance Company(5)
  $ 1,500,000       50,977       50,977                    
Aristeia International Limited
  $ 11,000,000       373,831       373,831                    
Aristeia Partners LP
  $ 1,500,000       50,977       50,977                    
Citadel Equity Fund Ltd.(5) 
  $ 15,000,000       509,770       509,770                    
Fore Convertible Master Fund, Ltd. 
  $ 15,000,000       509,770       509,770                    
Fore Erisa Fund, Ltd. 
  $ 2,500,000       84,961       84,961                    
Fore Multi Strategy Master Fund, Ltd. 
  $ 6,000,000       203,908       203,908                    
Forest Fulcrum Fund, LP(6)
  $ 229,000       7,782       7,782                    
Forest Global Convertible Fund, Limited, Class A-5
  $ 655,000       22,259       22,259                    
Forest Multi-Strategy Master Fund SPC, on behalf of its Multi-Strategy Segregated Portfolio
  $ 345,000       11,724       11,724                    
Grace Convertible Arbitrage Fund, Ltd. 
  $ 3,250,000       110,450       110,450                    
HFR CA Global Opportunity Master Trust
  $ 579,000       19,677       19,677                    
HFR RVA Select Performance Master Trust
  $ 155,000       5,267       5,267                    
Inflective Convertible Opportunity Fund, Ltd. 
  $ 2,100,000       71,367       71,367                    
Inflective Convertible Opportunity Fund, LP
  $ 850,000       28,886       28,886                    
Institutional Benchmarks Series — Ivan Segregated Acct. Ltd. 
  $ 600,000       20,390       20,390                    
JMG Capital Partners, LP
  $ 7,750,000       263,381       263,381                    
JMG Triton Offshore Fund, Ltd. 
  $ 7,750,000       263,381       263,381                    
LDG Ltd. 
  $ 266,000       9,039       9,039                    
Lyxor/ Forest Fund Ltd. 
  $ 878,000       29,838       29,838                    
Lyxor/ Inflective Convertible Opportunity Fund, Ltd. 
  $ 750,000       25,488       25,488                    
Man Mac 1, Ltd. 
  $ 6,000,000       203,908       203,908                    
MSS Convertible Arbitrage c/o TQA Investors
  $ 70,000       2,378       2,378                    
Nomura Securities International(6)
  $ 4,000,000       135,938       135,938                    
SG Cowen, LLC(6)
  $ 2,000,000       67,969       67,969                    

1


 

                                                 
    Principal       Number of            
    Amount of   Number of   Shares of            
    Notes   Shares of   Common   Principal   Number of    
    Beneficially   Common   Stock Issuable   Amount of   Shares of   Percentage of
    Owned Prior   Stock   Upon   Notes   Common Stock   Common Stock
    to the   Beneficially   Conversion of   Beneficially   Beneficially   Outstanding
    Offering and   Owned Prior   the Notes That   Owned Upon   Owned Upon   Upon
    That May   to the   May be   Completion of   Completion of   Completion of
Selling Securityholder   be Offered   Offering(1)   Offered(2)   the Offering(3)   the Offering(3)   the Offering(4)
                         
Sphinx Convertible Arbitrage SPC
  $ 242,000       8,224       8,224                    
Sphinx Fund c/o TQA Investors
  $ 275,000       9,345       9,345                    
TQA Master Fund, Ltd. 
  $ 2,836,000       96,380       96,380                    
TQA Master Plus Fund, Ltd. 
  $ 1,000,000       33,984       33,984                    
UBS Securities LLC(6)(7) 
  $ 1,724,000       58,589       58,589                    
Vicis Capital Master Fund
  $ 5,000,000       169,923       169,923                    
Zurich Institutional Benchmark Master Fund
  $ 553,000       18,793       18,793                    
All other holders of notes or future transferees, pledges, donees, assignees or successors of any such holders(8)(9)
  $ 12,643,000       429,668       429,668                    
 
(1)  Shares in this column include shares of common stock issuable upon conversion of the notes.
 
(2)  Assumes conversion of all of the securityholders’ notes at a conversion rate of 33.9847 shares of common stock per $1,000 principal amount of notes. This conversion rate is subject to adjustment, however, as described under “Description of the Notes — Conversion Rights.” As a result, the number of shares of common stock issuable upon conversion of the notes may increase or decrease in the future.
 
(3)  Assumes that each selling securityholder will sell all of the notes and common stock owned by the selling securityholder and covered by this prospectus.
 
(4)  Based upon 56,827,114 shares of common stock which is the number of shares of common stock outstanding as of March 7, 2006.
 
(5)  With respect to selling securityholders that are affiliates of broker-dealers, such entities have represented to us that they acquired their notes or underlying common stock in the ordinary course of business and, at the time of the purchase of the notes or the underlying common stock, such selling securityholders had no agreements or understandings, directly or indirectly, with any person to distribute the notes or underlying common stock. To the extent that we become aware that such entities did not acquire their notes or underlying common stock in the ordinary course of business or did have such an agreement or understanding, we will file a supplement to the prospectus to designate such affiliate as an “underwriter” within the meaning of the Securities Act.
 
(6)  This selling securityholder has identified itself as a registered broker-dealer and, accordingly, it is deemed to be, under the interpretations of the SEC, an “underwriter” within the meaning of the Securities Act. Please see “Plan of Distribution” for required disclosure regarding these selling securityholders.
 
(7)  UBS Securities LLC was the initial purchaser of the notes; however, the notes registered herein were acquired from a qualified institutional buyer following the initial issuance by the Company.
 
(8)  Information about other selling securityholders will be set forth in prospectus supplements or amendments, if required.
 
(9)  Assumes that any other holders of the notes or any future pledges, donees, assignees, transferees or successors of or from any other such holders of the notes, do not beneficially own any shares of common stock other than the common stock issuable upon conversion of the notes at the initial conversion rate.

2 GRAPHIC 2 y19683y1968300.gif GRAPHIC begin 644 y19683y1968300.gif M1TE&.#EA"P$<`-4@`,#!POCX^./)TIB:G-#0THB*C9"2E.CHZ?#P\+BYN["Q ML\C)RJI<=YQ!8<>3I:BIJ]C8V?CR]-6NO.K7WO'EZ94T5<"%F;%J@[EXCLZA ML*-/;-R\Q^#@X:"AI(XF2H""A?___P`````````````````````````````` M```````````````````````````````````````````````````````````` M`````````````````````````````````"'Y!`$``"``+``````+`1P```;_ M0)!0XBE>A,BDQXO0>N>$PNF\_HM+I\^(+-C2AE M34=2H@VAP\&H5+9H7@4?'QQUAXB)BDP("@H(BR!M'8.%941%#)%I4$42(`(" M$J-S:AV$AINJJZQ)#X0=JZ>69'%%@*UB`GB+LZFYP,%K!H0&LJAD$[S"7+9: MBK[,TM-"!&%*!(0$Q[1B6446U$P941C0R.+IK-F_S-%CSA--$Z$"$6.A\@*E M9G=%%>>ZJ1N8B`,Z:>^X*/NW)((#9YEP*9%0`8\'!TD<1-GH08DSB4@XB!2) M`,$"+PG:"8G&(8&7!0&6!"#PH(,"E2-%Q@30`0`(_P0Y4QUPV6&;D)DU;S*! MX/+!@B8M44)8D"`)!YX=4B(!.O):@*`QA1RHM&#DSYS7DB#`JH``@:I;%]1, M`&E)0A`!Y&:%$(N<$243G&GH$R6<$K\>&&@H@A&)1HY%E'R[R(20Y0&5+'<( MNY+0@@&6"0W@#&)!9L])0A=28#D!`-4<9FD.`.#T!PA)#H`./3I)`-G`C[[Z M8(#8A\T@7FL68C"T4-N$DH>.E23!Y4K4`UA7C5M)0@3&=W\`,;FQD`@5BV0X MOYAQ$O2>A%R@K&17%":8/!Q9(I(U(04Q<5#)`$G(9D!9PWWPE!"O%<7!`I;5 M!8)(NXGW`5T/AF:`:^(-,O\```E48HQ8Q)4%P6X^(;$;@'BQ1IU_1D'XP0-G MR9B=2):E`M1N98E4(RQ)^->;=-2]H@`$'/@W8H$'G6)`3."-U\DS2$RF"1+V M%<%/EOO=81Z6&S&1I09.*$-?BDC(!@`'KZ32W`<` MA!5`>+]D0XB$:X*0Y@<$,EB,$@;$TMR9;^H)9&H'L5DI7 MOM/_7`%I":&K$+>"-"69YT&&P3U+W-K$NTOPJH1RXT5J5:;]-LND0"%%FX2_ MWZJ4\+*E7JJB:JJ-V%RR0CP++,+*)FM9L5R$FU!F"7#&[V-%X.O8R9!54&L2 M^N9ZWZX&5VO9-7==S,15QA4;;KSJ<\7]!F=6QLY7^K//2 M?(X1`%.5C'J0H)LNR'(4*NO!+P@6M!RVK#,O,?;"-0.-1>KW)*G>PO" M;JD,+;#PRPHM.SHRG@F[$,:5N\1VG#I1^.]12QSW<(E6]D']P3O8+ZC%@=T8 M8$H2F4P>LJ&"!3##?^(AW/G$1+7W*D5\'!Y:^[D&- M%LHQROND,R@E0")BI$,?WO`'+FV@+UE<4TD`OI*I610J@+^3T)\(43;WK,H9 MYJ"",[YD'\/DQU54$`!BM`"2#43A@:,S`*$VQ9GP)2M^,Q'1XUZG,/7%D(;E M$PT"EH>.(2(J+:;9QG8^4*C8A/\!A@M"0(+D)#E#7:-PLRA`H`RP.LO`!&"\ M`Z+X-CB`_.P'"8'!PY0\$"MX2?**&8$,!5<&CN+][TYS[(X@1%,4`G1@-P7P M`@CF"`L1#2`VE""EFTPI'C"XQ#B-JHH7+E.4`ZBF`*A4Y5AXZ:&P^`=1"5`` M, MPC4`(30KU7KH4!"J2X1NHZ$!B!)Q4A&`8Q*G3TD@@$`/E!O9J.XW;E@3UPIP MT8?RK3:NC6.1)'!I"/^H;A(%W<8'%)`9`W1'54R@0#V2$8HUL`ILQ?,)5TBS MA@.T`RA,#090A,B!=L7)JFHA21.IXM=GT%K&(7&XG\ M8%$<**LD7T'&V,I:=@W.2P=\&L@%#5[VLZ`=@Q4SH0Z42?"$TPFM:E>+A"`` "`#L_ ` end -----END PRIVACY-ENHANCED MESSAGE-----